| 1 |
Hoang DM, Pham PT, Bach TQ, et al. Stem cell-based therapy for human diseases[J]. Signal Transduct Target Ther, 2022, 7(1):272.
|
| 2 |
Gong W, Wang F, He Y, et al. Mesenchymal stem cell therapy for oral inflammatory diseases:research progress and future perspectives[J]. Curr Stem Cell Res Ther, 2021, 16(2):165-174.
|
| 3 |
Nazim SM, Ahmad S. Stem cell research, regenerative medicine and challenges[J]. J Pak Med Assoc, 2023, 73(Suppl 1)(2):S143-S147.
|
| 4 |
郑颖, 邓诗碧, 陈方. 干细胞与再生医学技术发展态势研究[J]. 中国生物工程杂志, 2022, 42(4):111-119.
|
| 5 |
Blanc KL, Dazzi F, English K, et al. Isct msc committee statement on the us fda approval of allogenic bone-marrow mesenchymal stromal cells[J]. Cytotherapy, 2025, 27(4):413-416.
|
| 6 |
国家药品监督管理局. 国家药监局附条件批准艾米迈托赛注射液上市[EB/OL]. (2025-01-02)[2025-09-23].
URL
|
| 7 |
Cai J, Chen H, Xie S, et al. Research progress of totipotent stem cells[J]. Stem Cells Dev, 2022, 31(13-14):335-345.
|
| 8 |
刘中民, 康九红, 赵庆辉, 等. 适用于临床研究的间充质干细胞资源库建设与管理规范[J]. 中国研究型医院, 2024, 11(4):1-7.
|
| 9 |
Fan BS, Liu Y, Zhang JY, et al. Principles for establishment of the stem cell bank and its applications on management of sports injuries[J]. Stem Cell Res Ther, 2021, 12(1):307.
|
| 10 |
Kirkeby A, Nelander J, Hoban DB, et al. Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of parkinson's disease, stem-pd[J]. Cell Stem Cell, 2023, 30(10):1299-1314.
|
| 11 |
Cha Y, Park T, Leblanc P, et al. Current status and future perspectives on stem cell-based therapies for parkinson's disease[J]. J Mov Disord, 2023, 16(1):22-41.
|
| 12 |
何志旭. 中国人胚胎干细胞系的建立及胚胎干细胞诱导分化为造血干细胞的研究[R]. 贵阳：贵阳医学院, 2012-05-24.
|
| 13 |
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126(4):663-676.
|
| 14 |
Martins de Oliveira ML, Tura BR, Meira Leite M, et al. Creating an HLA-homozygous iPS cell bank for the Brazilian population:challenges and opportunities[J]. Stem Cell Reports, 2023, 18(10):1905-1912.
|
| 15 |
Maina MB, Isah MB, Marsh JA, et al. Somatic and Stem Cell Bank to study the contribution of African ancestry to dementia:African iPSC Initiative[J]. Alzheimers Dement, 2025, 21(4):e70145.
|
| 16 |
Escribá R, Beksac M, Bennaceur-Griscelli A, et al. Current landscape of iPSC haplobanks[J]. Stem Cell Rev Rep, 2024, 20(8):2155-2164.
|
| 17 |
Yoshida S, Kato TM, Sato Y, et al. A clinical-grade hla haplobank of human induced pluripotent stem cells matching approximately 40 % of the japanese population[J]. Med, 2023, 4(1):51-66.e10.
|
| 18 |
Kim J, Jo H, Ha H, et al. Korea national stem cell bank[J]. Stem Cell Res, 2021, 53:102270.
|
| 19 |
Ding D, Chang Y, Shyu W, et al. Human umbilical cord mesenchymal stem cells:a new era for stem cell therapy[J]. Cell Transplant, 2015, 24(3):339-347.
|
| 20 |
Algeri M, Lodi M, Locatelli F. Hematopoietic stem cell transplantation in thalassemia[J]. Hematol Oncol Clin North Am, 2023, 37(2):413-432.
|
| 21 |
Chen Y, Sakurai K, Maeda S, et al. Integrated collection of stem cell bank data, a data portal for standardized stem cell information[J]. Stem Cell Reports, 2021, 16(4):997-1005.
|
| 22 |
Ye J, Bates N, Soteriou D, et al. High quality clinical grade human embryonic stem cell lines derived from fresh discarded embryos[J]. Stem Cell Res Ther, 2017, 8(1):128.
|
| 23 |
Main H, Hedenskog M, Acharya G, et al. Karolinska institutet human embryonic stem cell bank[J]. Stem Cell Res, 2020, 45:101810.
|
| 24 |
上海市东方医院（同济大学附属东方医院）. 一种临床级人脐带间充质干细胞资源库多级库的构建方法：中国，CN202111227361.6[P]. 2021-12-24.
|
| 25 |
许志强. 脐带血已广泛应用到临床中国脐带血应用超4万例[N]. 南方网, 2024-11-20.
URL
|
| 26 |
FDA improves safety of human cells and tissues[J]. FDA Consum, 2005, 39(1):5.
|
| 27 |
von Auer F. [The implementation of european directives into national law, demonstrated by the example of the ec tissues and cells directive 2004/23/ec][J]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2008, 51(7):757-763.
|
| 28 |
Dwenger A, Strassburger J, Schwerdtfeger W. [Regulation (ec) no. 1394/2007 on advanced therapy medicinal products :incorporation into national law][J]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2010, 53(1):14-19.
|
| 29 |
国家卫生和计划生育委员会, 国家食品药品监督管理总局. 干细胞临床研究管理办法（试行）[EB/OL]. （2015-07-20）[2025-09-23].
URL
|
| 30 |
国家药品监督管理局食品药品审核查验中心. 细胞治疗产品生产质量管理指南（试行）[EB/OL]. （2022-10-28）[2025-09-23].
URL
|
| 31 |
国家药品监督管理局药品审评中心. 人源干细胞产品药学研究与评价技术指导原则（试行）[EB/OL].(2023-04-25)[2025-09-23].
URL
|
| 32 |
International Organization for Standardization. ISO 24651:2022 Biotechnology—Biobanking—Requirements for human mesenchymal stromal cells derived from bone marrow[S]. Geneva:International Organization for Standardization, 2022.
|
| 33 |
International Organization for Standardization. ISO 24603:2022 Biotechnology—Biobanking—Requirements for human and mouse pluripotent stem cells[S]. Geneva:International Organization for Standardization, 2022.
|
| 34 |
International Organization for Standardization. ISO/TS 22859:2022 Biotechnology—Biobanking—Requirements for human mesenchymal stromal cells derived from umbilical cord tissue[S]. Geneva:International Organization for Standardization, 2022.
|